Simparica Trio 0.12 mg

Simparica Trio 0.12 mg chewable tablets provide broad-spectrum protection for dogs against fleas, ticks, heartworm, and intestinal parasites. This oral medication combines moxidectin for effective parasite control, ensuring your pet's health and comfort.

Simparica Trio 0.12 mg is primarily used for the prevention and treatment of flea and tick infestations in dogs. It also helps in controlling heartworm disease and treating intestinal parasites. This medication is suitable for dogs that require comprehensive parasite protection in a single, convenient chewable tablet.

Common effects of Simparica Trio 0.12 mg may include reduced flea and tick activity within 24 hours of administration. It works by targeting the nervous system of parasites, leading to their paralysis and death. Some dogs may experience mild gastrointestinal upset or lethargy after taking the medication.

Simparica Trio 0.12 mg should be used with caution in dogs with a history of seizures or neurological disorders. It is important to follow the dosage instructions provided by your veterinarian to ensure the safety and effectiveness of the medication. Always store the tablets in a cool, dry place away from children and pets.

Simparica Trio 0.12 mg may interact with other medications, particularly those that affect the nervous system. It is important to inform your veterinarian about any other medications your dog is taking before starting this treatment. Avoid administering this medication with ivermectin or other macrocyclic lactones to prevent potential adverse reactions.